President Trump has threatened to levy tariffs of up to 200% on pharmaceutical imports. Lilly's margins could be negatively affected if the company absorbs the higher costs. The active ingredients of ...

Johnson & Johnson (NYSE:JNJ) is one of the Most Undervalued High Quality Stocks to Buy According to Hedge Funds. On July 10, ...

The pharmaceutical sector continues to stand out as a resilient and highly profitable corner of the market, even amid global ...

Getinge's quarterly earnings beat market expectations on Friday, driven by organic sales growth across its business areas and regions, as the medical equipment maker seeks ways beyond pricing to ...

Sales of several state firms which were on line to be privatized could not be completed due to time it took to follow proper ...

What bothers Japanese firms is Donald Trump's unpredictability and the complexity of the tariffs, according to JETRO.

Trump's tariff policies have torn up the global trade rule book. With baseline levies of 10% on all US imports and targeted ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even ...

The 30% tariff on European goods threatened by US President Donald Trump would, if implemented, be a game-changer for Europe, wiping out whole chunks of transatlantic commerce ...

TSMC's 30% growth is driven by soaring AI and HPC chip demand. Click to read more on my updated look at TSM and its Q2 ...